NOVAVAX
Novavax is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax recently initiated the development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, with Phase 1 clinical trial results expected in July of 2020. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivo... tal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.
NOVAVAX
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1987-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.novavax.com
Total Employee:
251+
Status:
Active
Contact:
(240) 268-2000
Total Funding:
2.38 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network Font Awesome Mobile Non Scaleable Content Euro IPv6 JsDelivr Cloudflare JS
Similar Organizations
AB-BIOTICS
AB-BIOTICS is a Spanish biotech company focused on research, development, protection and distribution of its own biotechnological solutions.
Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Bio-Cancer Treatment
Bio-Cancer Treatment is a clinical-stage biopharmaceutical company focused on the research and development of innovative biologics.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Curevo
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines.
Cytocentrics
Cytocentrics is a biotechnology company using its ion channel expertise to support the pharmaceutical industry.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Endo Pharmaceuticals Inc
Endo International plc is a global specialty pharmaceutical company focused on improving patients’ lives while creating value.
Entegrion
Entegrion is a life sciences company dedicated to providing innovative solutions.
Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Hinabiotech
Hinabiotech is a manufacturer of medicated and nutritional feed additives.
Inmagene Biopharmaceuticals
It is a leading biotech company focused on immunology-related therapeutic areas.
Innate Immunity
Innate Immunity is a biotechnology startup focused on plant and crop health.
KeifeRx
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
Aptose Biosciences
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class
LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
MorphoSys
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
NB Health Laboratory Japan
NB Health Laboratory is a biotechnology company specializing in the research and development of innovative new drugs.
NovoBiotic Pharmaceuticals
NovoBiotic Pharmaceuticals is a privately held, early stage biotechnology company focused on the discovery and development.
Oncurious
Oncurious NV is a Belgium-based biotech company focusing on the development of innovative oncology treatments.
OROX BioSciences
OROX BioSciences is a biotechnology start-up focused on the rapid discovery and development of novel small molecule medications.
Ncardia
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.
Prokaryotics
Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.
Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin focused on the discovery, development and commercialization of
SAI Life Sciences
SAI Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions.
TAXIS Pharmaceuticals
TAXIS Pharmaceuticals is focused on the discovery and development of pharmaceuticals.
Tetracore
Tetracore is a biotechnology company whose mission is to create and develop highly innovative diagnostic reagents, assays
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
UbiVac
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
UES
UES is a research company that provides research and development services.
vTv Therapeutics
vTv Therapeutics is a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs.
Current Advisors List
Board_member
Board_member
2020-11-01
Board_member
Current Employees Featured
Stanley C. Erck President ,CEO & Director @ Novavax
President ,CEO & Director
2009-01-01
Fred Driscoll Vice President & Chief Financial Officer & Treasurer @ Novavax
Vice President & Chief Financial Officer & Treasurer
2009-01-01
Karin Lövgren-Bengtsson Chief Scientific Officer @ Novavax
Chief Scientific Officer
Sven Andréasson SVP @ Novavax
SVP
2014-10-01
Filip Dubovsky Chief Medical Officer @ Novavax
Chief Medical Officer
2020-06-01
John Trizzino SVP, Chief Business Officer & CFO @ Novavax
SVP, Chief Business Officer & CFO
2018-03-01
Jill Hoyt SVP Human Resources @ Novavax
SVP Human Resources
2018-11-01
Gregory F. Covino Executive Vice President & Chief Financial Officer @ Novavax
Executive Vice President & Chief Financial Officer
2020-11-01
Bobby Lodin CFO @ Novavax
CFO
James Kelly EVP & Chief Financial Officer @ Novavax
EVP & Chief Financial Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-09-05 | BXB Exchange | BXB Exchange acquired by Novavax | 56 K USD |
| 2013-12-02 | Isconova AB | Isconova AB acquired by Novavax | N/A |
Investors List
Government of United States of America
Government of United States of America investment in Grant - Novavax
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Novavax
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Novavax
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Novavax
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Novavax
Innovations Kapital
Innovations Kapital investment in Post-IPO Equity - Novavax
Key Employee Changes
Official Site Inspections
http://www.novavax.com Semrush global rank: 328.1 K Semrush visits lastest month: 186.52 K
- Host name: 104.17.175.108
- IP address: 104.17.175.108
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novavax"
Novavax - Wikipedia
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists …See details»
Meet Our Leadership - Novavax
Novavax’ compliance program is designed to prevent, detect, and respond to potential instances of non-compliance. Novavax declares, in good faith as of May 24, 2024, that the company is in compliance with a Comprehensive …See details»
Who we are - Novavax
Novavax is a global biotechnology company focusing on driving value via our proven recombinant nanoparticle and Matrix-M™ technology through partnerships and R&D. To do this, we are …See details»
Is the Novavax COVID Vaccine Better Than mRNA
Oct 16, 2023 Compared with mRNA vaccines, the Novavax booster seems to have a lower risk of causing myocarditis or pericarditis—heart conditions that occasionally occur, especially in young men—although it ...See details»
Novavax - Crunchbase Company Profile & Funding
Novavax is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious …See details»
Novavax Investor Relations | Novavax
Novavax is a global biotechnology company with a proven vaccine technology, focused on developing our R&D assets and establishing partnerships to help protect health. View our earnings and investor presentations, latest press …See details»
The industry heavyweight behind Novavax’s push to bounce back
Mar 25, 2025 In particular, Novavax is leveraging its technology platform, which boosts immune response to create more effective vaccines through the use of a recombinant protein-based …See details»
Novavax - Org Chart, Teams, Culture & Jobs - The Org
View Novavax's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Log in. Sign up. Novavax. Track. Novavax is a late-stage biotechnology company …See details»
Novavax Reports Fourth Quarter and Full Year 2024 …
Feb 28, 2025 $225 million in U.S. BLA & Market Authorizations Milestones. Novavax is eligible to receive from Sanofi a $175 million milestone payment upon the approval of the COVID-19 U.S. BLA and inclusive of JN.1 and pre-filled …See details»
Novavax COVID-19 vaccine - Wikipedia
Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries. [57] In 2020 it was reported, that the vaccine would be …See details»
Novavax's Updated Protein-based COVID-19 Vaccine Now an …
GAITHERSBURG, Md., Nov. 28, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced …See details»
Moderna and Novavax shares plunge after key FDA official steps …
1 day ago Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’ BY …See details»
What We Do: Vaccine Research & Proven Technology | Novavax
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships Our approach to science We …See details»
A Guide to Novavax’s COVID-19 Vaccine - FactCheck.org
Aug 12, 2022 A health service worker prepares a Novavax COVID-19 vaccine. Photo by Patrick van Katwijk/Getty Images. There were no differences by ethnicity and race except for Hispanic …See details»
Novavax's COVID-19 Vaccine: Your Questions Answered
Sep 3, 2024 The original Novavax vaccine was found to be 90% effective in its initial clinical trials. The FDA authorization for the updated 2024-2025 Novavax vaccine was based on non …See details»
Novavax Announces Changes to Board of Directors
Mar 10, 2025 Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology …See details»
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before …
2 days ago Novavax is expected to post a loss of $0.43 per share for the current quarter, representing a year-over-year change of +59.1%. Over the last 30 days, the Zacks Consensus …See details»
Novavax Nuvaxovid COVID-19 vaccine - Canada.ca
Name: Novavax Nuvaxovid™ COVID-19 vaccine; Novavax Nuvaxovid™ XBB.1.5 Omicron subvariant COVID-19 vaccine Manufacturer: Novavax Inc. Type: protein-based vaccine …See details»
Our commitments - Novavax
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our …See details»
New FDA commissioner agreed to oust top vaccine regulator
1 day ago Vaccine manufacturers Moderna and Novavax saw their stocks drop sharply when the market opened Monday. Biotechnology Innovation Organization President and CEO John …See details»